Drug Type Affibody, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action antagonists |
Mechanism HER2 antagonists(Receptor tyrosine-protein kinase erbB-2 antagonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gastrooesophageal junction cancer | Phase 2 | - | - | |
| Metastatic breast cancer | Phase 2 | - | - | |
| Non-Small Cell Lung Cancer | Phase 2 | - | - |






